Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 86Neoplasms 3Osteoporosis 2Neoplasm Metastasis 2Lower Urinary Tract Symptoms 2Hirsutism 2Bulbo-Spinal Atrophy, X-Linked 2Breast Neoplasms 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Primary Dysautonomias 1Ovarian Neoplasms 1Kidney Diseases 1Hypertension 1Gynecomastia 1Fallopian Tube Neoplasms 1Erectile Dysfunction 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1Adenocarcinoma 1

Interventions

Sildenafil Citrate 2udenafil 1methyl 3-mercaptopropionimidate 1bicalutamide 1alpha-Tocopherol 1Vitamin E 1Tamoxifen 1Tadalafil 1Tacrolimus 1Restraint, Physical 1Psychiatric Rehabilitation 1Preservation, Biological 1Pentoxifylline 1Menogaril 1Long-Term Synaptic Depression 1Intraoperative Neurophysiological Monitoring 1GPI 1485 1Exercise 1Erythropoietin 1Early Intervention, Educational 1Dutasteride 1Cell- and Tissue-Based Therapy 1Atorvastatin 1Arginine 1ArginMax 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Erectile Dysfunction × bicalutamide × Clear all
NCT00866554 2023-06-02

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

CHU de Quebec-Universite Laval

Phase 2 Completed
60 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Lower Urinary Tract Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡